Inactivated vaccines may not provide adequate protection in immunosuppressed patients with rheumatic diseases
Open Access
- 1 February 2022
- journal article
- letter
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 81 (2) , 295-296
Abstract
A second family with the autosomal recessive disorder now referred to as the limb/pelvis-hypoplasia/aplasia syndrome is reported. It is speculated that the gene for this rare skeletal dysplasia may be confined to the Middle East gene pool. The disorder has been shown to be diagnosable prenatally in a pregnancy at risk by using ultrasonography.Keywords
Funding Information
- Indian Rheumatology Association
This publication has 7 references indexed in Scilit:
- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohortAnnals of the Rheumatic Diseases, 2021
- Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19The Lancet Microbe, 2021
- SARS-CoV-2 Variants in Patients with ImmunosuppressionNew England Journal of Medicine, 2021
- AB0546 5 YEARS FOLLOW-UP OF PSORIATIC ARTHRITIS PATIENTS TREATED ACCORDING TREAT-TO-TARGET STRATEGY. PRELIMINARY RESULTSAnnals of the Rheumatic Diseases, 2021
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021
- Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemicRheumatology International, 2021
- Covid-19 and Kidney TransplantationNew England Journal of Medicine, 2020